Copy number variations across the blood-brain barrier in multiple sclerosis

Ann Clin Transl Neurol. 2022 Jul;9(7):962-976. doi: 10.1002/acn3.51573. Epub 2022 May 13.

Abstract

Objective: Multiple sclerosis (MS) is a neuroinflammatory disease where immune cells cross the blood-brain barrier (BBB) into the central nervous system (CNS). What predisposes these immune cells to cross the BBB is still unknown. Here, we examine the possibility that genomic rearrangements could predisposespecific immune cells in the peripheral blood to cross the BBB and form sub-populations of cells involved in the inflammatory process in the CNS.

Methods: We compared copy number variations in paired peripheral blood mononuclear cells (PBMCs) and cerebrospinal fluid (CSF) cells from MS patients. Thereafter, using next generation sequencing, we studied the T-cell receptor beta (TRB) locus rearrangements and profiled the αβ T cell repertoire in peripheral CD4+ and CD8+ T cells and in the CSF.

Results: We identified deletions in the T-cell receptor alpha/delta (TRA/D), gamma (TRG), and TRB loci in CSF cells compared to PBMCs. Further characterization revealed diversity of the TRB locus which was used to describe the character and clonal expansion of T cells in the CNS. T-cell repertoire profiling from either side of the BBB concluded that the most frequent clones in the CSF samples are unique to an individual. Furthermore, we observed a difference in the proportion of expanded T-cell clones when comparing samples from MS patients in relapse and remission with opposite trends in CSF and peripheral blood.

Interpretation: This study provides a characterization of the T cells in the CSF and might indicate a role of expanded clones in MS pathogenicity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood-Brain Barrier
  • CD8-Positive T-Lymphocytes
  • DNA Copy Number Variations
  • Humans
  • Leukocytes, Mononuclear
  • Multiple Sclerosis*
  • Receptors, Antigen, T-Cell

Substances

  • Receptors, Antigen, T-Cell

Grants and funding

This work was funded by Nilsson‐Ehle Endowments; NEURO Sweden; Stiftelsen Goljes Minne.